Laplace is a medical device company that develops transcatheter tricuspid valve technology.
Laplace Interventional has raised $22.0M in total funding. The most recent round was Series C. The last funding was announced in March 2025.
Laplace Interventional's investors include Mayo Clinic, Shangbay Capital, Aphelion Capital, Features Capital, gbeta.
Laplace Interventional is headquartered in Plymouth, United States.
Laplace is a medical device company that develops transcatheter tricuspid valve technology.
Laplace Interventional is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Laplace Interventional — Funding & Investors." VCBacked, March 16, 2025, https://www.vcbacked.co/company/laplace-interventional. Accessed August 1, 2026.
VCBacked. (2025). Laplace Interventional — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/laplace-interventional
{{cite web |title=Laplace Interventional — Funding & Investors |url=https://www.vcbacked.co/company/laplace-interventional |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated